Completed clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events and no viral rebounds with equivalent time to sustained symptom resolution; ...
BioPhy announces acquisition by Intrinsic Clinical Systems. The AI-driven platform will continue advancing quality and ...
Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...
Subgroup analysis in clinical trials constitutes a vital methodological tool to uncover differential treatment effects within specified categories of patients. This approach enables researchers to ...
CRF acquired Spark Therapeutics, Inc.’s SPK-7001 CHM gene therapy assets and is analyzing long-term data to identify ...
Novel lipid metabolism-related gene signature associated with clinical and immune features in lung adenocarcinoma patients experiencing lymph node metastasis. Mean fold-change vs. baseline (p < 0.05) ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support ...
This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge. Results: There were 31 studies that met ...
Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current antiviral therapies, such as neuraminidase inhibitors and ...
Real-time and early detection of minute changes in the functioning of the cardiovascular system is crucial for managing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results